Omnicell, Inc.

OMCL

US68213N1090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 17/07/2024 BST			5-day change	1st Jan Change
28.66 ^USD	+3.99%		+11.91%	-23.84%

07-01	Omnicell, Inc.(NasdaqGS:OMCL) dropped from Russell 3000 Growth Index	CI
07-01	Omnicell, Inc.(NasdaqGS:OMCL) dropped from Russell 3000E Growth Index	CI

Omnicell, Inc. Seeks Acquisitions

January 11, 2018 at 05:00 am

Omnicell, Inc. (NasdaqGS:OMCL) building upon the platform with additional acquisitions.

Latest news about Omnicell, Inc.

Omnicell, Inc.(NasdaqGS:OMCL) dropped from Russell 3000 Growth Index	06-30	CI
Omnicell, Inc.(NasdaqGS:OMCL) dropped from Russell 3000E Growth Index	06-30	CI
Omnicell, Inc.(NasdaqGS:OMCL) dropped from Russell 2000 Growth Index	06-30	CI
Omnicell, Inc.(NasdaqGS:OMCL) dropped from Russell 2000 Growth-Defensive Index	06-30	CI
Omnicell, Inc.(NasdaqGS:OMCL) dropped from Russell 2500 Growth Index	06-30	CI
Omnicell, Inc.(NasdaqGS:OMCL) dropped from Russell Small Cap Comp Growth Index	06-30	CI
Transcript : Omnicell, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:40 PM	05-15
Omnicell Shares Rise After Q1 Non-GAAP Earnings, Revenue Beat Estimates	05-02	MT
Transcript : Omnicell, Inc., Q1 2024 Earnings Call, May 02, 2024	05-02
(OMCL) OMNICELL Sees Q2 Revenue Range $250M - $260M	05-02	MT
(OMCL) OMNICELL Expects Fiscal Year 2024 EPS Range $0.90 - $1.40	05-02	MT
Earnings Flash (OMCL) OMNICELL Reports Q1 Revenue $246.2M, vs. Street Est of $236.8M	05-02	MT
Earnings Flash (OMCL) OMNICELL Reports Q1 EPS $0.03, vs. Street Est of $-0.09	05-02	MT
Omnicell, Inc. Provides Earnings Guidance for Second Quarter and Full Year 2024	05-02	CI
Omnicell, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
North American Morning Briefing : Stock Futures -2-	05-02	DJ
Omnicell, Inc. Announces XT Amplify	04-16	CI
Omnicell, Inc. Announces Executive Changes	02-29	CI
Wells Fargo Adjusts Price Target on Omnicell to $26 From $28, Maintains Equal-Weight Rating	02-09	MT
Omnicell Fiscal Q4 Non-GAAP Net Income Flat, Revenue Falls; Sets Outlook	02-08	MT
Transcript : Omnicell, Inc., Q4 2023 Earnings Call, Feb 08, 2024	02-08
(OMCL) OMNICELL Sees Q1 Revenue Range $232M - $242M	02-08	MT
(OMCL) OMNICELL Expects Fiscal Year 2024 EPS Range $0.90 - $1.40	02-08	MT
Earnings Flash (OMCL) OMNICELL Reports Q4 Revenue $258.8M, vs. Street Est of $255.6M	02-08	MT
Omnicell, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-08	CI

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Companyâs XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Sector

Advanced Medical Equipment & Technology

Calendar

31/07/2024 - Q2 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Omnicell, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

28.66 USD

Average target price

33.14 USD

Spread / Average Target

+15.64%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
OMNICELL, INC.	-23.84%	1.27B
VEEVA SYSTEMS INC.	-5.50%	30.25B
PRO MEDICUS LIMITED	+40.35%	9.47B
SECTRA AB	+31.81%	4.33B
EVOLENT HEALTH, INC.	-36.88%	2.49B
VERADIGM INC.	-6.48%	1.66B
LUNIT INC.	-42.92%	972M
SIMULATIONS PLUS, INC.	-3.96%	885M
B-SOFT CO.,LTD.	-50.69%	687M
SURGICAL SCIENCE SWEDEN AB	-29.70%	609M

Medical Software & Technology Services

Omnicell, Inc.

Equities

OMCL

US68213N1090

Advanced Medical Equipment & Technology

Omnicell, Inc. Seeks Acquisitions

Latest news about Omnicell, Inc.

Chart Omnicell, Inc.

Company Profile

Income Statement Evolution

Ratings for Omnicell, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Software & Technology Services